Biomerica, Inc.
BMRA
$0.5725
-$0.0315-5.22%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.40% | 1.72% | 1.41% | -43.30% | -65.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.40% | 1.72% | 1.41% | -43.30% | -65.81% |
| Cost of Revenue | 7.93% | 11.58% | -1.78% | -43.63% | -65.80% |
| Gross Profit | -32.62% | -46.88% | 36.32% | -40.56% | -65.81% |
| SG&A Expenses | -4.38% | 1.23% | -9.88% | -11.96% | -14.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.05% | 1.80% | -6.21% | -27.55% | -45.46% |
| Operating Income | 6.92% | -1.86% | 11.84% | 6.54% | -12.98% |
| Income Before Tax | 6.81% | -0.18% | 16.26% | 10.74% | -8.23% |
| Income Tax Expenses | -84.81% | -68.06% | -17.65% | 0.21% | 406.41% |
| Earnings from Continuing Operations | 7.83% | 0.61% | 16.27% | 10.67% | -9.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.83% | 0.61% | 16.27% | 10.67% | -9.35% |
| EBIT | 6.92% | -1.86% | 11.84% | 6.54% | -12.98% |
| EBITDA | 7.17% | -1.81% | 11.93% | 3.53% | -18.38% |
| EPS Basic | 14.23% | 12.47% | 30.23% | 29.60% | 8.63% |
| Normalized Basic EPS | 13.27% | 11.83% | 30.27% | 29.68% | 9.61% |
| EPS Diluted | 11.89% | 11.21% | 28.79% | 29.55% | 9.17% |
| Normalized Diluted EPS | 13.27% | 11.83% | 30.27% | 29.68% | 9.61% |
| Average Basic Shares Outstanding | 6.07% | 11.49% | 18.82% | 26.78% | 21.99% |
| Average Diluted Shares Outstanding | 6.07% | 11.49% | 18.82% | 26.78% | 21.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
